Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma
Clinical trial NCT04166734 · TERMINATED
Trial details
- NCT number
- NCT04166734
- Sponsor
- Royal Marsden NHS Foundation Trust
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-12
- Primary completion
- 2023-07-25
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.